We are live on
!
Find out more
Los Angeles Capital Management Portfolio holdings
AUM
$27.2B
1-Year Est. Return
43.16%
This Fund
S&P 500
This Quarter
Est. Return
+13.16%
1 Year Est. Return
+43.16%
3 Year Est. Return
+177.72%
5 Year Est. Return
+262.7%
10 Year Est. Return
+1,121.27%
AUM
$22.5B
AUM Growth
+$1.93B
(+9.4%)
Cap. Flow
+$256M
Cap. Flow
% of AUM
1.14%
Top 10 Holdings %
Top 10 Hldgs %
26.61%
Holding
1,346
New
164
Increased
337
Reduced
605
Closed
194
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$426M |
| 2 |
Deere & Co
DE
|
+$212M |
| 3 |
NVIDIA
NVDA
|
+$149M |
| 4 |
W.W. Grainger
GWW
|
+$140M |
| 5 |
Netflix
NFLX
|
+$135M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$196M |
| 2 |
Home Depot
HD
|
+$189M |
| 3 |
Gilead Sciences
GILD
|
+$145M |
| 4 |
Oracle
ORCL
|
+$145M |
| 5 |
Microsoft
MSFT
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.24% |
| 2 | Financials | 13.5% |
| 3 | Healthcare | 12.02% |
| 4 | Consumer Discretionary | 11.94% |
| 5 | Industrials | 11.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
Brookdale Senior Living
BKD
$3B
| $734K | ﹤0.01% |
248,821
+147,496
| +146% | +$424K |
|
|
HTBK
752
DELISTED
Heritage Commerce
HTBK
| $733K | ﹤0.01% |
87,950
-2,165
| -2% | -$24.8K |
|
753
US Foods
USFD
$23.8B
| $728K | ﹤0.01% |
19,708
| – | – |
|
754
Warrior Met Coal
HCC
$4.98B
| $728K | ﹤0.01% |
+19,827
| New | +$733K |
|
|
KRTX
755
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $721K | ﹤0.01% |
3,971
-480
| -11% | -$91.8K |
|
756
Buckle
BKE
$2.31B
| $719K | ﹤0.01% |
20,154
-18,031
| -47% | -$739K |
|
|
RCM
757
DELISTED
R1 RCM Inc. Common Stock
RCM
| $719K | ﹤0.01% |
47,915
-9,817
| -17% | -$134K |
|
758
Vitamin Cottage Natural Grocers
NGVC
$646M
| $715K | ﹤0.01% |
60,850
-1,101
| -2% | -$11.4K |
|
759
Terex
TEX
$7.57B
| $711K | ﹤0.01% |
14,690
-319
| -2% | -$16.3K |
|
|
DENN
760
DELISTED
Denny's
DENN
| $709K | ﹤0.01% |
+63,545
| New | +$739K |
|
761
Cencora
COR
$59.2B
| $709K | ﹤0.01% |
4,426
+64
| +1% | +$10.2K |
|
762
Dollar General
DG
$26.9B
| $708K | ﹤0.01% |
3,365
-23,323
| -87% | -$5.24M |
|
763
Lindblad Expeditions
LIND
$2.26B
| $702K | ﹤0.01% |
73,385
-2,168
| -3% | -$21.8K |
|
764
Inspired Entertainment
INSE
$164M
| $693K | ﹤0.01% |
+54,192
| New | +$782K |
|
765
Beam Therapeutics
BEAM
$2.74B
| $690K | ﹤0.01% |
22,548
-2,410
| -10% | -$95.1K |
|
766
TriNet
TNET
$3.22B
| $690K | ﹤0.01% |
8,556
-1,923
| -18% | -$151K |
|
|
OLPX
767
DELISTED
Olaplex Holdings
OLPX
| $689K | ﹤0.01% |
161,351
| – | – |
|
|
VRAY
768
DELISTED
ViewRay, Inc.
VRAY
| $685K | ﹤0.01% |
197,834
-20,950
| -10% | -$88.7K |
|
|
GTLS
769
DELISTED
Chart Industries
GTLS
| $684K | ﹤0.01% |
5,457
+3,698
| +210% | +$476K |
|
|
ETRN
770
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $684K | ﹤0.01% |
118,298
+205
| +0.2% | +$1.31K |
|
771
John B. Sanfilippo & Son
JBSS
$1.01B
| $681K | ﹤0.01% |
7,025
-700
| -9% | -$62.5K |
|
772
Costamare
CMRE
$1.74B
| $676K | ﹤0.01% |
71,852
-2,060
| -3% | -$20.3K |
|
773
Matador Resources
MTDR
$6.39B
| $668K | ﹤0.01% |
14,013
-54,479
| -80% | -$3.06M |
|
774
Wintrust Financial
WTFC
$11B
| $664K | ﹤0.01% |
9,103
-162,762
| -95% | -$13.9M |
|
775
Roblox
RBLX
$27.1B
| $659K | ﹤0.01% |
14,648
-21,850
| -60% | -$835K |
|
Similar funds
FDCDDQ
WP
N
PCH
VAI
Los Angeles Capital Management's Q1 2023 Portfolio in Review
As of Q1 2023, Los Angeles Capital Management held 1,346 positions worth $22.5B, up 9.4% from $20.6B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Los Angeles Capital Management's Q1 2023 filing shows 164 new, 337 increased, 605 reduced and 194 closed positions. Its largest new stake was Bio-Rad Laboratories Class A: 184,796 shares worth $88.5M. The largest sale was Pfizer, an estimated $196M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.
- Los Angeles Capital Management's largest Q1 2023 buy was Bio-Rad Laboratories Class A: 184,796 shares worth $88.5M.
- Los Angeles Capital Management added most to Visa in Q1 2023, an estimated $426M increase.
- Los Angeles Capital Management's biggest Q1 2023 reduction was Pfizer, cutting an estimated $196M.
- Los Angeles Capital Management fully exited Regions Financial in Q1 2023, selling an estimated $50.4M.
- Los Angeles Capital Management's ten largest holdings make up 27% of its $22.5B portfolio in Q1 2023.
- Los Angeles Capital Management opened 164 new positions and closed 194 in Q1 2023.
- Los Angeles Capital Management's portfolio value rose 9.4% quarter-over-quarter to $22.5B.
Based on Los Angeles Capital Management's 13F filing for Q1 2023, filed 4 May 2023.